Distal myopathy 2

Revision as of 19:02, 19 August 2012 by Prashanthsaddala (talk | contribs) (Created page with "__NOTOC__ {{SI}} {{CMG}} '''''Synonyms and keywords:''''' == Overview == Distal myopathy 2 is a condition characterized by weakness of specific muscles that begins in adult...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Distal myopathy 2

Articles

Most recent articles on Distal myopathy 2

Most cited articles on Distal myopathy 2

Review articles on Distal myopathy 2

Articles on Distal myopathy 2 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Distal myopathy 2

Images of Distal myopathy 2

Photos of Distal myopathy 2

Podcasts & MP3s on Distal myopathy 2

Videos on Distal myopathy 2

Evidence Based Medicine

Cochrane Collaboration on Distal myopathy 2

Bandolier on Distal myopathy 2

TRIP on Distal myopathy 2

Clinical Trials

Ongoing Trials on Distal myopathy 2 at Clinical Trials.gov

Trial results on Distal myopathy 2

Clinical Trials on Distal myopathy 2 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Distal myopathy 2

NICE Guidance on Distal myopathy 2

NHS PRODIGY Guidance

FDA on Distal myopathy 2

CDC on Distal myopathy 2

Books

Books on Distal myopathy 2

News

Distal myopathy 2 in the news

Be alerted to news on Distal myopathy 2

News trends on Distal myopathy 2

Commentary

Blogs on Distal myopathy 2

Definitions

Definitions of Distal myopathy 2

Patient Resources / Community

Patient resources on Distal myopathy 2

Discussion groups on Distal myopathy 2

Patient Handouts on Distal myopathy 2

Directions to Hospitals Treating Distal myopathy 2

Risk calculators and risk factors for Distal myopathy 2

Healthcare Provider Resources

Symptoms of Distal myopathy 2

Causes & Risk Factors for Distal myopathy 2

Diagnostic studies for Distal myopathy 2

Treatment of Distal myopathy 2

Continuing Medical Education (CME)

CME Programs on Distal myopathy 2

International

Distal myopathy 2 en Espanol

Distal myopathy 2 en Francais

Business

Distal myopathy 2 in the Marketplace

Patents on Distal myopathy 2

Experimental / Informatics

List of terms related to Distal myopathy 2

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords:

Overview

Distal myopathy 2 is a condition characterized by weakness of specific muscles that begins in adulthood. It is a form of muscular dystrophy that specifically involves muscles in the throat, lower legs, and forearms. Muscles farther from the center of the body, like the muscles of the lower legs and forearms, are known as distal muscles.

Muscle weakness in the ankles is usually the first symptom of distal myopathy 2. The weakness can also affect muscles in the hands, wrists, and shoulders. At first, the muscle weakness may be on only one side of the body, but both sides are eventually involved. This muscle weakness can slowly worsen and make actions like walking and lifting the fingers difficult.

Another characteristic feature of distal myopathy 2 is weakness of the vocal cords and throat. This weakness initially causes the voice to sound weak or breathy (hypophonic). Eventually, the voice becomes gurgling, hoarse, and nasal. The weakness can also cause difficulty swallowing (dysphagia).

Historical Perspective

Classification

Pathophysiology

Genetics

Distal myopathy 2 is inherited in an autosomal dominant pattern, which means one copy of the altered MATR3 gene in each cell is sufficient to cause the disorder. A mutation in the MATR3 gene has been identified in people with distal myopathy 2. This gene provides instructions for making a protein called matrin 3, which is found in the nucleus of the cell as part of the nuclear matrix. The nuclear matrix is a network of proteins that provides structural support for the nucleus and aids in several important nuclear functions.

The function of the matrin 3 protein is unknown. This protein can attach to (bind) RNA, which is a chemical cousin of DNA. Some studies indicate that matrin 3 binds and stabilizes a type of RNA called messenger RNA (mRNA), which provides the genetic blueprint for proteins. Matrin 3 may also bind certain abnormal RNAs that might lead to nonfunctional or harmful proteins, thereby blocking the formation of such proteins. Other studies suggest that the matrin 3 protein may be involved in cell survival.

The MATR3 gene mutation identified in people with distal myopathy 2 changes a single protein building block (amino acid) in the matrin 3 protein. The effect of this mutation on the function of the protein is unknown, although one study suggests that the mutation may change the location of the protein in the nucleus. Researchers are working to determine how this gene mutation leads to the signs and symptoms of distal myopathy 2.

Associated Conditions

Causes

Differentiating type page name here from other Diseases

Epidemiology and Demographics

The prevalence of distal myopathy 2 is unknown. At least two families with the condition have been described in the scientific literature.

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Symptoms

Family History

Physical Examination

Appearance of the Patient

Vital Signs

Skin

Head

Eyes

Ear

Nose

Throat

Heart

Lungs

Abdomen

Extremities

Neurologic

Other

Laboratory Findings

Biomarker Studies

CT

MRI

Ultrasound

References


Template:WikiDoc Sources